New specific biomarker for human prostate cancer prognosis
Date: 11.2.2014
Technology offer: New specific biomarker for human prostate cancer prognosis
Reference: TOFR20131113002
Summary: An academic French laboratory developed a process based on detection of a microRNA (Ribonucleic acid molecule) as a molecular biomarker dedicated to the prognosis of cancers of the male reproductive system, including prostate cancer. This microRNA is flexible to use, non invasive and easily automatable and suitable for use on industrial scale. Industrial partners are sought for licence agreement or technical cooperation.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
